Journal of Neuroscience Research · 2000 · 241 citations · 41 references
MedicineNeurobiologyNeuroscienceMolecular NeuroscienceNeuroendocrinologyNeuropharmacologyHormonal InfluencesHormonal RegulationHormonal TherapyHypothalamic-pituitary-gonadal AxisNeuroprotectionSteroid Hormone SignalingAlzheimer Disease NeuroprotectionEstrogen ReceptorsGlutamate-induced NeurotoxicityNeuroprotective MechanismsNeuroprotective ResponsesPhosphatidylinositol 3-Kinase PathwayPhosphatidylinositol 3-Kinase-akt PathwayPhosphatidylinositol 3-Kinase-akt Signaling
It has been shown that estrogen replacement in menopausal women is effective in slowing down the progression of cognitive impairment in Alzheimer's disease. Although recent studies have demonstrated the neuroprotective effects of estrogen, the precise mechanism of neuroprotection has not been elucidated. In the present study, we show that the phosphatidylinositol 3-kinase (PI3-K) cascade is involved in the neuroprotective mechanism stimulated by estrogen. Exposure to glutamate reduced the viability of rat primary cortical neurons. Pretreatment with 10 nM 17beta-estradiol significantly attenuated the glutamate-induced toxicity. This neuroprotective effect of 17beta-estradiol was blocked by co-administration with LY294002, a selective PI3-K inhibitor, but not by co-administration with PD98059, a selective mitogen activated protein kinase kinase inhibitor. Pretreatment with ICI182780, a specific estrogen receptor antagonist, also blocked the neuroprotection. Immunoblotting assay revealed that treatment with 17beta-estradiol induced the phosphorylation of Akt/PKB, an effector immediately downstream of PI3-K. These results suggest that PI3-K mediates the neuroprotective effect of 17beta-estradiol against glutamate-induced neurotoxicity.
41
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Ming‐Xin Tang, Diane M. Jacobs, Yaakov Stern et al. · The Lancet · 1996 · 1.6K citations